BCL2 and Cachexia: Thereby, decreasing the intracellular availability and oxidative shift in GSH status may also disinhibit pro-apoptotic signals [67], contributing to loss of muscle mass with PDAC, though the data on Casp3, Bax and BCL2 expression with PDAC do not support this notion, at least within the presently studied stage of cachexia.